Skip to main content

Table 2 Ovarian reserve test (AMH and AFC) and basal-FSH of patients included in the review

From: Salpingectomy before assisted reproductive technologies: a systematic literature review

OVARIAN RESERVE

Authors & Years

Patients

AMH ± SD

p

AFC ± SD/range

p

FSH ± SD/range

p

Surrey et al. [8]

a) 32 SLP (HY)

Type: not specified

b) 15 PTO (HY)

c) 35 no surgery (TF no HY)

d) 12 tubal ligation

n.r.

 

n.r.

 

a) 7.07 ± 0.12

b) 6.65 ± 0.42

c) 7.08 ± 0.23

d) 7.47 ± 0.25

ns

Chan et al. [13]

32 SLP (ECP)

a) 18 unilateral LPS

b) 14 unilateral LPT

n.r

-

Operated site

a) 5. 0 (3.0-7.3)

b) 6.5 (1.8-10.3)

Non operated site

a) 7.5 (4.8-8.3)

b) 4.0 (2.8-9.3)

a) .05

b) ns

n.r

-

Gelbaya et al. [10]

a) 40 SLP (HY)

Type: 16 unilateral, 24 bilateral

b) 25 PTD

Type: 9 unilateral, 16 bilateral

c) 103 no surgery

(tubal factor, no HY)

n.r

-

n.r

-

IU/L

a) 6.8 ± 1.3 pre

7.61 ± 2.31 post

b) 6.4 ± 1.5 pre

6.35 ± 1.51 post

c) 6.6 ± 2.3 pre

6.71 ± 2.32 post

a) .05

b) ns

c) ns

Sezik et al. [16]

a) 12 total hysterectomy + bilateral SLP

b) 12 total hysterectomy without SLP

n.r

-

n.r

-

a) Basal 4.8 ± 1.4

1 month 4.2 ± 1.6

6 months 4.4 ± 2.1

b) Basal 5.9 ± 1.6

1 month 5.2 ± 1.6

6 months 5.5 ± 1.2

ns

Nakagawa et al. [17]

a) 6 SLP (HY)

Type: not specified

b) 11 PTD (HY)

n.r

-

n.r

-

IU/L

Before surgery

a) 8.0 ± 2.9

b) 6.8 ± 1.1

After surgery

a) 8.6 ± 4.0

b) 14.1 ± 9.3

a) ns

b) ns

Orvieto et al. [18]

a) 15 uni/bilateral SLP

(HY)

n.r

-

Before surgery

a) 5.6 ± 2.5 affected side

11.4 ± 4.5 both side

After surgery

a) 4.7 ± 2.3 affected side

9.5 ± 4.9 both side

a) .05

n.r

-

Xi et al. [20]

a) 76 SLP (ECP)

- 44 unilateral

- 32 bilateral

b) 80 no surgery (healthy subjects)

n.r

-

n.r

-

IU/L

Before surgery

a) 6.9 ± 1.5

7.5 ± 1.5

7.0 ± 1.5

After surgery

a) 7.2 ± 1.6

7.3 ± 1.2

7.2 ± 1.4

b) 7.2 ± 1.8

a) ns

Na et al. [21]

a) 41 SLP (HY)

Type: not specified

b) 56 sclerotherapy (HY)

n.r

-

n.r

-

IU/L

a) 8.2 ± 4.6

b) 10.9 ± 17.1

ns

Grynnerup et al. [25]

a) 16 SLP (HY)

Type: not specified

b) 42 no surgery (TF, with or without HY)

c) 13 no surgery (unexplained infertility, no HY)

pmol/L

a) 16,1 (5,2-54)

b) 23,4 (3,5-50)

c) 21.8 (12–64)

a) ns

b) ns

c) ns

n.r

-

n.r

-

Uyar et al. [23]

a) 33 patients (ECP)

- 26 unilateral SLP

- 3 salpingostomy

b) 49 MTX (ECP)

c) 80 no surgery

n.r

-

a) 10.1 ± 3.5

b) 10.3 ± 4.1

c) 10.1 ± 3.5

a) ns

b) ns

c) ns

IU/L

a) 7.7 ± 3.8

b) 7.7 ± 2.3

c) 7.9 ± 1.9

a) ns

b) ns

c) ns

Ni et al. [22]

60 SLP (ECP, HY)

a) 26 bilateral

b) 34 unilateral

c) 23 PTO (HY)

d) 51 no surgery

(TF, no HY)

pg/mL

a) 90.00

b) 100.00

c) 100.00

d) 110.00

a) ns

b) ns

c) ns

d) ns

a) 9

b) 10

c) 11

d) 11

a) ns

b) ns

c) ns

d) ns

IU/L

a) 7.35 ± 1.59

b) 7.17 ± 1.16

c) 7.64 ± 2.10

d) 7.13 ± 1.57

a) ns

b) ns

c) ns

d) ns

Findley et al. [26]

a) 15 hysterectomy + bilateral SLP

b) 15 hysterectomy with no SLP

a) Basal 2.26 ± 2.72

4–6 weeks 1.03 ± 1.04

3 months 1.86 ± 1.99

b) Basal 2.25 ± 2.57

4–6 weeks 1.25 ± 2.09

3 months 1.82 ± 3.12

ns

n.r

-

n.r

-

Hill et al. [27]

a) 36 SLP (ECP)

Type: unilateral

b) 153 MTX (ECP)

n.r

-

a) 10 (3–50) pre

10 (4–45) post

b) 12 (1–53) pre

13 (1–60) post

a) ns

b) ns

IU/L

a) 7.2 (2.6 -16.0) pre

7.9 (5.1-10.4) post

b) 6.9 (2.4-14.2) pre

7.2 (2.3-16.3) post

a) ns

b) ns

Pereira et al. [29]

a) 37 SLP (ECP)

Type: unilateral

b) 107 MTX (ECP)

n.r

-

n.r

-

mIU/mL

a) 4.98 ± 2.19 pre

4.87 ± 2.97 post

b) 4.81 ± 2.75 pre

4.94 ± 2.05 post

a) ns

b) ns

Ye et al. [28]

124 SLP (HY, ECP, TOA)

a) 83 unilateral

b) 41 bilateral

c) 74 no surgery (infertility, no TF)

fmol/mL

a) 167,56 ± 127,03

b) 127,11 ± 93,23

c) 183.48 ± 104,37

.05

a) 10,7 ± 3,62

b) 9,58 ± 3,73

c) 11,2 ± 4,16

ns

mIU/mL

a) 8.42 ± 2.3

b) 9.13 ± 3.2

c) 7.85 ± 2.69

.05

Venturella et al. [31]

a) 91 SLP standard

b) 95 SLP wide

Type: bilateral

ng/mL

Before surgery

a) 0.93 ± 1.13

b) 0.86 ± 1.01

Δ After surgery

a) -0.09 ± 0.24 (Δ)

b) -0.07 ± 0.22 (Δ)

a) ns

b) ns

Before surgery

a) 7.8 ± 4.23

b) 6.82 ± 4.68

Δ After surgery

a) -0.33 ± 0.73 (Δ)

b) -0.26 ± 0.61 (Δ)

a) ns

b) ns

mIU/mL

Before surgery

a) 12.9 ± 9.71

b) 12.39 ± 7.88

After surgery

a) 0.47 ± 0.86

b) 0.37 ± 0.84

a) ns

b) ns

  1. n.r, not reported; ns, not significant; LPS, laparoscopy; LPT, laparotomy; MTX, methotrexate; PTD, proximal tubal division; PTO, Proximal tubal occlusion; ° On 21 patients (23 contro-lateral ligation excluded)